A. Lindgren

4.1k total citations · 1 hit paper
53 papers, 3.1k citations indexed

About

A. Lindgren is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, A. Lindgren has authored 53 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in A. Lindgren's work include Breast Cancer Treatment Studies (8 papers), Global Cancer Incidence and Screening (6 papers) and Estrogen and related hormone effects (6 papers). A. Lindgren is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Global Cancer Incidence and Screening (6 papers) and Estrogen and related hormone effects (6 papers). A. Lindgren collaborates with scholars based in Sweden, United States and Italy. A. Lindgren's co-authors include Lars Holmberg, Jonas Bergh, Hans Nordgren, Mats Inganäs, S. Sjögren, Eva Hellmén, Göran Liljegren, Jan Frisell, Làszló Tabár and Torbjörn Norberg and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

A. Lindgren

52 papers receiving 2.9k citations

Hit Papers

Breast cancer screening with mammography: overview of Swe... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lindgren Sweden 22 1.5k 1.0k 620 579 510 53 3.1k
Arne Wallgren Sweden 35 1.8k 1.1× 1.6k 1.5× 964 1.6× 619 1.1× 757 1.5× 93 3.8k
H.T. Ford United Kingdom 33 1.8k 1.2× 1.2k 1.2× 780 1.3× 807 1.4× 675 1.3× 77 3.5k
Karl von Smitten Finland 36 1.4k 0.9× 1.1k 1.1× 583 0.9× 297 0.5× 1.2k 2.3× 99 3.7k
William R. Jewell United States 27 2.3k 1.5× 966 0.9× 444 0.7× 574 1.0× 772 1.5× 104 3.7k
William L. Donegan United States 27 1.4k 0.9× 1.1k 1.1× 688 1.1× 648 1.1× 756 1.5× 63 3.0k
Alex McMillan United States 33 944 0.6× 716 0.7× 542 0.9× 712 1.2× 587 1.2× 57 3.5k
Claes Silfverswärd Sweden 32 1.0k 0.6× 878 0.8× 608 1.0× 465 0.8× 785 1.5× 109 3.4k
Alexia Savignoni France 30 862 0.6× 832 0.8× 397 0.6× 455 0.8× 240 0.5× 108 2.4k
Gary N. Schwartz United States 29 1.3k 0.8× 1.2k 1.1× 470 0.8× 1.0k 1.7× 305 0.6× 89 3.7k
Amanda Hummer United States 35 1.3k 0.9× 613 0.6× 487 0.8× 661 1.1× 750 1.5× 46 3.5k

Countries citing papers authored by A. Lindgren

Since Specialization
Citations

This map shows the geographic impact of A. Lindgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lindgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lindgren more than expected).

Fields of papers citing papers by A. Lindgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lindgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lindgren. The network helps show where A. Lindgren may publish in the future.

Co-authorship network of co-authors of A. Lindgren

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lindgren. A scholar is included among the top collaborators of A. Lindgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lindgren. A. Lindgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pawlas, Jan & A. Lindgren. (2025). Expanding the Reach of Sustainable Solid-Phase Peptide Synthesis: One-Pot, Metal-Free Alloc Removal–Peptide Coupling. Organic Letters. 27(12). 2891–2896. 2 indexed citations
2.
Lindgren, A., et al.. (2025). Natural microbial exposure populates the maternal fetal interface with diverse T cells. Frontiers in Immunology. 16. 1616491–1616491.
3.
Lindgren, A., et al.. (2004). Development of cognitive functions in children with rolandic epilepsy. Epilepsy & Behavior. 5(6). 903–910. 88 indexed citations
4.
Eskelinen, M, et al.. (2004). Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer. European Journal of Surgical Oncology. 30(5). 495–500. 22 indexed citations
5.
Hårdemark, Hans‐Göran, A. Lindgren, Bo Norrving, et al.. (2001). Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study. Stroke. 32(11). 2567–2574. 159 indexed citations
6.
Holmberg, Lars, et al.. (2001). Pre-operative oestradiol levels – relation to survival in breast cancer. European Journal of Surgical Oncology. 27(2). 152–156. 16 indexed citations
7.
Ekström, Anna Mia, L. B. Signorello, Lars‐Erik Hansson, et al.. (1999). Evaluating Gastric Cancer Misclassification: a Potential Explanation for the Rise in Cardia Cancer Incidence. JNCI Journal of the National Cancer Institute. 91(9). 786–790. 173 indexed citations
8.
Sjögren, S., Mats Inganäs, A. Lindgren, Lars Holmberg, & Jonas Bergh. (1998). Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.. Journal of Clinical Oncology. 16(2). 462–469. 258 indexed citations
9.
Lindgren, A., E Bagge, Åke Cederblad, et al.. (1997). Schilling and protein‐bound cobalamin absorption tests are poor instruments for diagnosing cobalamin malabsorption. Journal of Internal Medicine. 241(6). 477–484. 18 indexed citations
10.
Liljegren, Göran, A. Lindgren, Jonas Bergh, et al.. (1997). Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Annals of Oncology. 8(3). 235–241. 39 indexed citations
11.
Sjögren, S., Mats Inganäs, Leona Holmberg, et al.. (1996). Response on p53. JNCI Journal of the National Cancer Institute. 88. 1500. 4 indexed citations
12.
Torre, Michele, Rolf Larsson, Peggy Nygren, et al.. (1996). Differential expression of glutathione S-transferase Pi in normal, preneoplastic and neoplastic breast tissue.. Human Pathology. 3. 11. 1 indexed citations
13.
Lindgren, A., Susanna M. Wallerstedt, & Rolf Olsson. (1996). Prevalence of Crohn's Disease and Simultaneous Occurrence of Extraintestinal Complications and Cancer An Epidemiologic Study in Adults. Scandinavian Journal of Gastroenterology. 31(1). 74–78. 52 indexed citations
14.
Jansson, T., Mats Inganäs, S. Sjögren, et al.. (1995). p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings.. Journal of Clinical Oncology. 13(11). 2745–2751. 76 indexed citations
15.
Tholander, Bengt, et al.. (1992). Immunohistochemical detection of CA-125 and carcinoembryonic antigen in ovarian tumors in relation to corresponding preoperative serum levels. International Journal of Gynecological Cancer. 2(5). 263–270. 9 indexed citations
16.
Tholander, Bengt, et al.. (1992). Tissue expression of CA-125 and carcinoembryonic antigen in ovarian carcinoma in relation to nuclear DNA content, histologic grade, and patient survival. International Journal of Gynecological Cancer. 2(5). 271–279. 3 indexed citations
17.
Stendahl, U, et al.. (1989). Expression of Placental Alkaline Phosphatase in Epithelial Ovarian Tumours. Tumor Biology. 10(3). 126–132. 11 indexed citations
18.
Hellmén, Eva, A. Lindgren, F Linell, P. Matsson, & A. Nilsson. (1988). Comparison of Histology and Clinical Variables to DNA Ploidy in Canine Mammary Tumors. Veterinary Pathology. 25(3). 219–226. 35 indexed citations
19.
Wilander, Erik, Sven Påhlman, Johan Sällström, & A. Lindgren. (1987). Neuron-specific enolase expression and neuroendocrine differentiation in carcinomas of the breast.. PubMed. 111(9). 830–2. 5 indexed citations
20.
Pousette, Åke, et al.. (1986). Quantitation of estrogen receptor in seventy-five specimens of breast cancer: comparison between an immunoassay (Abbott ER-EIA monoclonal) and a [3H]estradiol binding assay based on isoelectric focusing in polyacrylamide gel.. PubMed. 46(8 Suppl). 4308s–4309s. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026